Stocks

MONTREAL, QUEBEC--(Marketwired - Oct. 10, 2017) - Pursuant to the early warning requirements of National Instrument 62-103, Knight Therapeutics Inc. (TSX:GUD) ("Knight") announced today an increase in its ownership of Crescita Therapeutics Inc. ("Crescita"). On October 6, 2017, Knight acquired 566,471 common shares of …

MONTRÉAL, QUÉBEC--(Marketwired - 10 oct. 2017) - En vertu des exigences d'alerte précoce de la norme canadienne 62-103, Thérapeutique Knight inc. (TSX:GUD) (« Knight »), a annoncé aujourd'hui un accroissement de sa participation dans Crescita Therapeutics Inc. (« Crescita »). En date du 6 …

TORONTO, Oct. 02, 2017 (GLOBE NEWSWIRE) -- PIMCO Canada, part of leading global investment management firm PIMCO, has launched two actively managed bond exchange-traded fund (ETF) series in Canada. These innovatively structured ETF series are additional access points to two established mutual funds – …

TORONTO, ON--(Marketwired - October 02, 2017) - Transaction Highlights: Sprott Asset Management ("SAM") to acquire common shares of Central Fund of Canada Limited ("CFCL") and right to administer and manage CFCL's assets for C$120 million in cash and stockUpon completion of the transaction, all …

OAKVILLE, Ontario, Sept. 29, 2017 (GLOBE NEWSWIRE) -- Harvest Portfolios Group Inc. (the “Manager”) of Energy Leaders Income Fund, (TSX:HEN.UN), (the "Fund") announces that the Fund will terminate on or about November 30, 2017 (the “Termination Date). Unitholders are not required to take any …

VANCOUVER, British Columbia, Sept. 26, 2017 (GLOBE NEWSWIRE) -- Oceanic Iron Ore Corp. (TSX-V:FEO) (“Oceanic”, or the “Company”) is pleased to announce the completion of a non-brokered financing in an aggregate amount of $810,000 (the “Financing”). The subscribers to the Financing will be issued …

TORONTO, Sept. 25, 2017 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:IPCI) (“Intellipharmaceutics” or the “Company”), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled- and targeted-release oral solid dosage drugs, today provided an update on its RexistaTM, …